Date published: 2025-10-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

SLC26A10 Activators

Chemical activators of SLC26A10 include a diverse array of compounds that can enhance the protein's function through various biochemical pathways. Forskolin is known to activate adenylate cyclase, which leads to an increase in cAMP levels within the cell. This rise in cAMP can activate protein kinase A (PKA) and other cAMP-responsive elements that can phosphorylate SLC26A10, thereby increasing its transporter activity. Similarly, IBMX, a non-selective inhibitor of phosphodiesterases, prevents the breakdown of cAMP, thus sustaining elevated levels of this messenger that contribute to the activation of SLC26A10. The compound Dibutyryl-cAMP, a cell-permeable analog of cAMP, directly mimics the action of elevated cAMP and activates PKA, which then can phosphorylate and activate SLC26A10. Another compound, N6-Benzoyl-cAMP, selectively activates PKA and is likely to promote the activation of SLC26A10 through similar phosphorylation events.

In addition to pathways involving cAMP, other signaling molecules also play a role in the activation of SLC26A10. Genistein, a tyrosine kinase inhibitor, can alter phosphorylation patterns in cells, which may result in the enhanced activity of SLC26A10. PMA, which activates protein kinase C (PKC), and A23187, an ionophore that increases intracellular calcium, can both influence the phosphorylation state of proteins and may activate SLC26A10 indirectly through calcium-dependent or PKC-mediated signaling pathways. EGTA, by chelating extracellular calcium, might trigger intracellular signaling cascades that lead to the activation of SLC26A10 in an effort to compensate for altered calcium levels. Biochanin A modulates various kinase pathways, which could lead to the phosphorylation and subsequent activation of SLC26A10. LY294002, while primarily a PI3K inhibitor, can cause upregulation of compensatory regulatory mechanisms within the cell, which may include the activation of SLC26A10 through alternative signaling pathways. Lastly, Clofilium Tosylate, by blocking potassium channels, may induce cellular mechanisms to maintain ion balance, including the activation of SLC26A10, as a response to the changes in ion homeostasis. Each of these chemicals, through their unique interactions with cellular signaling pathways, can contribute to the activation of SLC26A10, underlining the multifaceted regulation of this protein.

SEE ALSO...

Items 11 to 11 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Clofilium tosylate

92953-10-1sc-391228
sc-391228A
25 mg
100 mg
$428.00
$1020.00
1
(0)

Potassium channel blocker that may lead to changes in cellular ion homeostasis, potentially activating SLC26A10 as part of the cell's response to maintain ion balance.